Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles: Therapeutics, Targets, and Development

Identification of SK3 channel as a new mediator of breast cancer cell migration

Marie Potier, Virginie Joulin, Sébastien Roger, Pierre Besson, Marie-Lise Jourdan, Jean-Yves LeGuennec, Philippe Bougnoux and Christophe Vandier
Marie Potier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginie Joulin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sébastien Roger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Besson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Lise Jourdan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Yves LeGuennec
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Bougnoux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Vandier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-06-0194 Published November 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2006 to March 2021

AbstractFull-text HTMLPDF
Total207542822354

Cited By

Article Information

Volume 5, Issue 11, pp. 2946-2953

DOI 
https://doi.org/10.1158/1535-7163.MCT-06-0194
PubMed 
17121942

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • September 11, 2006
  • April 10, 2006
  • July 26, 2006
  • Published first November 22, 2006.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Marie Potier1,
  2. Virginie Joulin2,
  3. Sébastien Roger1,
  4. Pierre Besson1,
  5. Marie-Lise Jourdan1,
  6. Jean-Yves LeGuennec1,
  7. Philippe Bougnoux1 and
  8. Christophe Vandier1
  1. 1Inserm E 211, Nutrition, Croissance et Cancer and Université François Rabelais, Tours, France and 2FRE 2939-Centre National de la Recherche Scientifique, Génomes et Cancers, Institut Gustave Roussy, Villejuif, France
  1. Requests for reprints: Christophe Vandier, Inserm E-0211, Nutrition Croissance et Cancer, University Francois Rabelais, 10 boulevard Tonnelle, Tours, F-37000 France. Phone: 33-2-4736-6024; Fax: 33-2-4736-6226. E-mail: christophe.vandier{at}univ-tours.fr
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 5 (11)
November 2006
Volume 5, Issue 11
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of SK3 channel as a new mediator of breast cancer cell migration
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identification of SK3 channel as a new mediator of breast cancer cell migration
Marie Potier, Virginie Joulin, Sébastien Roger, Pierre Besson, Marie-Lise Jourdan, Jean-Yves LeGuennec, Philippe Bougnoux and Christophe Vandier
Mol Cancer Ther November 1 2006 (5) (11) 2946-2953; DOI: 10.1158/1535-7163.MCT-06-0194

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of SK3 channel as a new mediator of breast cancer cell migration
Marie Potier, Virginie Joulin, Sébastien Roger, Pierre Besson, Marie-Lise Jourdan, Jean-Yves LeGuennec, Philippe Bougnoux and Christophe Vandier
Mol Cancer Ther November 1 2006 (5) (11) 2946-2953; DOI: 10.1158/1535-7163.MCT-06-0194
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
  • Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors
  • WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
Show more Research Articles: Therapeutics, Targets, and Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement